Mycobacterium research and diagnosis
Moving in bioRxiv, medRxiv, Applied and environmental microbiology, mSystems, eLife, Genome Medicine, Immunity, Nature Microbiology.
- Moved this week
- 0
Rebuilt
Moved this week
Nothing in this area has moved yet this week.
Latest in Mycobacterium research and diagnosis
Newest first · last 60 days
Semapimod inhibits L-leucine uptake in Mycobacterium tuberculosis, reducing bacterial load in infected mice despite no in vitro efficacy.
- Open access
Tobramycin increases Mycobacterium abscessus survival by inducing whiB7, promoting persistent infection in cystic fibrosis airway conditions.
- Open access
Migration increased genetic diversity of Mycobacterium tuberculosis in Hamburg but did not significantly change local transmission patterns, which remained lineage-specific.
- Open access
Autodissemination stations reduce Aedes notoscriptus mosquito populations by 70% and lower Buruli ulcer cases by 83% in urban Melbourne, Australia.
- Open access
Browse JClub
Journals this month
- bioRxiv5569
- medRxiv1746
- Environ Res485
- PNAS463
- Sci Adv439
- JAMA255
- Cell Rep210
- BMJ205
- Nat Commun177
- Environ Pollution170
- Lancet149
- Science138
- NEJM119
- Applied & Environ Microbio116
- Curr Biol116
- J Exp Bot115
- mBio109
- Nature104
Moving areas, week to 3 Oct 2026
- Single-cell and spatial transcriptomics10
- Artificial Intelligence in Healthcare and Education8
- CAR-T cell therapy research7
- Neuroinflammation and Neurodegeneration Mechanisms6
- Lung Cancer Treatments and Mutations5
- Diabetes Treatment and Management4
- Pancreatic and Hepatic Oncology Research4
- Photosynthetic Processes and Mechanisms4
- Genomics and Chromatin Dynamics4
- Gut microbiota and health4